Antineoplastic Drugs Market Analysis By Drug Class(Cytotoxic, Hormonal Therapy, Targeted Therapy), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies) & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 231
- CATEGORY
- Healthcare & Life Sciences
The global antineoplastic drugs market size was valued at USD 130 billion in 2021 and is projected to reach around USD 245 billion in 2030 exhibiting a CAGR of 8.0% in the forecasted period.
The growing incidence of cancer and rising demand for treatment drugs are anticipated to drive the market. The most common cancers were lung (1.69 million deaths), colorectal (774 000 deaths), and breast (571 000 deaths). Increasing elderly population, technological advancements, and advancements in antineoplastic Drugs.
The rising number of new incidences of neoplasms across the world, as well as the growing demand for low-cost medicines to cure them, has impelled the increase of the anti-neoplastic drugs market. As per the World Health Organization, one in each five men and one in every six women will have cancer in their lifetime, with one in each eight men and one in each eleven women dying from it. Several factors for the increasing cancer burden, comprising population increase and aging, and fluctuating prevalence of definite cancers linked to social and economic development. The amount of government initiatives intended at improving caused by cancer, has boosted anti-neoplastic drugs market growth. Rising investment in cancer research by international corporations owing to increasing cancer prevalence is projected to boost the market over the forecasted period. Moreover, the market's anticipated growth is associated to increasing cancer cases and the health situations among cancer sufferers is budding. The increasing frequency of cancer, and the number of mortalities desire for cost-effective medicines over the predicted timeframe.
Several health systems are gradually investing in research and development to challenge the COVID-19 pandemic. ZINC, CHEMBL, FDA-approved medicines, and molecules in clinical trials were all investigated for potential compounds. Medicines for the management of COVID-19 are being established by screening both new and older drugs for their probability to decrease symptoms and stop viral replication. As a result of the current epidemic, the anti-neoplastic drugs market is expected to benefit owing to the need to find a cure for COVID-19. Moreover, according to the American Cancer Society, about 1.8 million new cancer cases were expected to be detected during the prediction period, with nearly 606,520 cancer deaths happening in the United States. Resulting in the rising prevalence of a broader range of diseases in all age groups, and their global impact, are driving demand for the market.
Drug Class Insights
in 2021, the targeted therapy market category had a 58% market share of the overall market and was expected to grow at a significant CAGR. For better and improved anticancer treatments and dramatically shorten time to market, market participants are forming co-development partnerships. This is owing to the growth in demand for anticancer therapies that have fewer side effects. One such development is the use of targeted medicines, which function just against cancer cells while being totally harmless to healthy cells.
Distribution Channel Insights
Hospital pharmacies represented the highest market share, with around 45% in 2021, owing to the rising number of individuals looking for cancer disease diagnosis and treatment in hospitals. Moreover, higher expenditure on purchasing anticancer drugs for better treatment increases the segment’s growth.
Region Insights
North America lead the global anticancer drugs market with a dominant share in 2021, and is anticipated to witness fast growth over the forecasted period. The North America market is ruled by the U.S. due to its larger economy, attractive reimbursement and higher prevalence of cancers.
Europe, is anticipated to be led by Germany. The UK and France, are other major nations anticipated to witness substantial growth in the global market owing to enormous presence of major players. There has been a certain shift of the illnesses concerning the Asia Pacific regions such as China, and India. Rise in disease incidence in emerging regions has augmented the market draw of the global market for antineoplastic drugs due to higher demand. China and India are boosting a large revenue market owing to unmet requirements and the high mortality rates of cancer in the region.
Africa region have a lower incidence of cancers. The Middle East and Africa market is predicted to be dominated by the gulf nations due to their high income and rising expanse of healthcare.
Key Companies Insights
To stay competitive in the global market, players are using new strategies such as new product development, mergers and acquisitions, joint ventures, and geographic expansions.
Some of the key players operating in the global antineoplastic drugs market include:
· Hoffmann-La Roche
· Amgen
· Bristol-Myers Squibb
· Baxter Healthcare
· Boehringer Ingelheim
· Aspen
· Bayer AG
· Teva pharmaceutical Industries
· Johnson & Johnson
· Merc & Co.
· Other players
Some of the Recent Developments:
· In 2020, Boehringer Ingelheim and Oxford BioTherapeutics Ltd. have formed cooperation to find additional selective targets for strategic cancer indications to develop first-in-class cancer medicines. Using its T-cell engager, cancer vaccine, and oncolytic virus platforms, the company will use OBT's OGAP platform to uncover novel target opportunities for new immune therapeutics.
· In 2020, ImmunityBio, Inc. and NantKwest, Inc. joined in March 2021 to form a premier late-stage cell therapy and immunotherapy firm specifying in oncology and infectious illnesses.
Segments
By Drug Class
· Cytotoxic
· Hormonal Therapy
· Targeted Therapy
o Monoclonal antibodies
o Small molecule inhibitors
By Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
By Geography
· North America
o U.S.
o Canada
o Mexico
· Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
· Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
· Latin America
o Brazil
o Argentina
o Colombia
· MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Reasons to Purchase Antineoplastic Drugs Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Product Overview and Scope of Antineoplastic Drugs
1.2 Antineoplastic Drugs Segment by Type
1.2.1 Global Antineoplastic Drugs Sales Growth Rate Comparison by Type (2022-2030)
1.2.2 Chemotherapeutic Agents
1.2.3 Biological/Immunotherapeutic Agents
1.2.4 Personalized Medicine
1.3 Antineoplastic Drugs Segment by Application
1.3.1 Antineoplastic Drugs Sales Comparison by Application: (2022-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 Global Antineoplastic Drugs Market Size Estimates and Forecasts
1.4.1 Global Antineoplastic Drugs Revenue 2016-2030
1.4.2 Global Antineoplastic Drugs Sales 2016-2030
1.4.3 Antineoplastic Drugs Market Size by Region: 2016 Versus 2022 Versus 2030
2 Antineoplastic Drugs Market Competition by Manufacturers
2.1 Global Antineoplastic Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antineoplastic Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antineoplastic Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antineoplastic Drugs Manufacturing Sites, Area Served, Product Type
2.5 Antineoplastic Drugs Market Competitive Situation and Trends
2.5.1 Antineoplastic Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antineoplastic Drugs Players Market Share by Revenue
2.5.3 Global Antineoplastic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antineoplastic Drugs Retrospective Market Scenario by Region
3.1 Global Antineoplastic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Antineoplastic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Antineoplastic Drugs Market Facts & Figures by Country
3.3.1 North America Antineoplastic Drugs Sales by Country
3.3.2 North America Antineoplastic Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antineoplastic Drugs Market Facts & Figures by Country
3.4.1 Europe Antineoplastic Drugs Sales by Country
3.4.2 Europe Antineoplastic Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antineoplastic Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Antineoplastic Drugs Sales by Region
3.5.2 Asia Pacific Antineoplastic Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antineoplastic Drugs Market Facts & Figures by Country
3.6.1 Latin America Antineoplastic Drugs Sales by Country
3.6.2 Latin America Antineoplastic Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antineoplastic Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Antineoplastic Drugs Sales by Country
3.7.2 Middle East and Africa Antineoplastic Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antineoplastic Drugs Historic Market Analysis by Type
4.1 Global Antineoplastic Drugs Sales Market Share by Type (2016-2021)
4.2 Global Antineoplastic Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Antineoplastic Drugs Price by Type (2016-2021)
5 Global Antineoplastic Drugs Historic Market Analysis by Application
5.1 Global Antineoplastic Drugs Sales Market Share by Application (2016-2021)
5.2 Global Antineoplastic Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Antineoplastic Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Hoffmann-La Roche
6.1.1 Hoffmann-La Roche Corporation Information
6.1.2 Hoffmann-La Roche Description and Business Overview
6.1.3 Hoffmann-La Roche Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hoffmann-La Roche Product Portfolio
6.1.5 Hoffmann-La Roche Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bristol-Myers Squibb Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Baxter Healthcare Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Aspen Global
6.6.1 Aspen Global Corporation Information
6.6.2 Aspen Global Description and Business Overview
6.6.3 Aspen Global Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aspen Global Product Portfolio
6.6.5 Aspen Global Recent Developments/Updates
6.7 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer AG Product Portfolio
6.7.5 Bayer AG Recent Developments/Updates
6.8 Teva pharmaceutical Industries
6.8.1 Teva pharmaceutical Industries Corporation Information
6.8.2 Teva pharmaceutical Industries Description and Business Overview
6.8.3 Teva pharmaceutical Industries Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Teva pharmaceutical Industries Product Portfolio
6.8.5 Teva pharmaceutical Industries Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Johnson & Johnson Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Merc & Co.
6.10.1 Merc & Co. Corporation Information
6.10.2 Merc & Co. Description and Business Overview
6.10.3 Merc & Co. Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Merc & Co. Product Portfolio
6.10.5 Merc & Co. Recent Developments/Updates
6.11 Pfize
6.11.1 Pfize Corporation Information
6.11.2 Pfize Antineoplastic Drugs Description and Business Overview
6.11.3 Pfize Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pfize Product Portfolio
6.11.5 Pfize Recent Developments/Updates
6.12 Accord Healthcare
6.12.1 Accord Healthcare Corporation Information
6.12.2 Accord Healthcare Antineoplastic Drugs Description and Business Overview
6.12.3 Accord Healthcare Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Accord Healthcare Product Portfolio
6.12.5 Accord Healthcare Recent Developments/Updates
6.13 Genentech
6.13.1 Genentech Corporation Information
6.13.2 Genentech Antineoplastic Drugs Description and Business Overview
6.13.3 Genentech Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Genentech Product Portfolio
6.13.5 Genentech Recent Developments/Updates
6.14 Lundbeck
6.14.1 Lundbeck Corporation Information
6.14.2 Lundbeck Antineoplastic Drugs Description and Business Overview
6.14.3 Lundbeck Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Lundbeck Product Portfolio
6.14.5 Lundbeck Recent Developments/Updates
6.15 AbbVie
6.15.1 AbbVie Corporation Information
6.15.2 AbbVie Antineoplastic Drugs Description and Business Overview
6.15.3 AbbVie Antineoplastic Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 AbbVie Product Portfolio
6.15.5 AbbVie Recent Developments/Updates
7 Antineoplastic Drugs Manufacturing Cost Analysis
7.1 Antineoplastic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antineoplastic Drugs
7.4 Antineoplastic Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antineoplastic Drugs Distributors List
8.3 Antineoplastic Drugs Customers
9 Antineoplastic Drugs Market Dynamics
9.1 Antineoplastic Drugs Industry Trends
9.2 Antineoplastic Drugs Growth Drivers
9.3 Antineoplastic Drugs Market Challenges
9.4 Antineoplastic Drugs Market Restraints
10 Global Market Forecast
10.1 Antineoplastic Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antineoplastic Drugs by Type (2022-2030)
10.1.2 Global Forecasted Revenue of Antineoplastic Drugs by Type (2022-2030)
10.2 Antineoplastic Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antineoplastic Drugs by Application (2022-2030)
10.2.2 Global Forecasted Revenue of Antineoplastic Drugs by Application (2022-2030)
10.3 Antineoplastic Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antineoplastic Drugs by Region (2022-2030)
10.3.2 Global Forecasted Revenue of Antineoplastic Drugs by Region (2022-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI